Clinical trial Recruiting at 1 site Observational Ages 20 and up

Understanding muscle loss in patients with chronic lung diseases

Official title: Epidemiological Study of Sarcopenia in Patients With Chronic Lung Diseases: A Prospective Registry Cohort Study

Run by Taichung Veterans General Hospital · NCT06280443 · Data updated 2026-11-12

This study looks at how muscle loss affects people with chronic lung diseases like COPD and ILD to see how common it is and how it relates to their overall health.

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment300 (estimated)
SponsorTaichung Veterans General Hospital
Academic / other
Locations1 site (Taichung)
StatusRecruiting
StartedNovember 25, 2022
Main results expectedOctober 13, 2024
Study endsSeptember 30, 2032
Registry record updatedApril 4, 2024
Trial IDNCT06280443 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are outpatients aged 20 and older with COPD or ILD who do not require hospitalization.

Probably not a fit

Patients who are bedridden, unable to walk, or have terminal illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on outpatients diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD) at Taichung Veterans General Hospital. Participants will undergo a series of assessments including the SARC-Calf questionnaire, grip strength tests, and various physical performance tests to evaluate the prevalence of sarcopenia. The study aims to analyze body composition using bioelectrical impedance analysis and dual-energy X-ray absorptiometry. Data collected will help explore the continuity of care and medical resource utilization among these patients.

Why it matters

Potential benefit: If successful, this study could enhance understanding of muscle loss in chronic lung disease patients, potentially leading to better management strategies.

How similar studies have gone: Other studies have shown success in assessing sarcopenia in chronic diseases, indicating that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
2. Those who meet the conditions for frailty diagnosis after assessment by the Frailty Scale
3. Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources
4. Age\>=20

Exclusion Criteria:

1. Patients who refuse to sign the consent form
2. Patients who are bed ridden or unable to walk due to physical disabilities
3. Patients with terminal cancer or human acquired immunodeficiency syndrome
4. Patients with edema (pitting edema +2)

Where it's running

  • Taichung Veterans General Hospital
    Taichung, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.